Group 1: Cannabis Industry - MSOX, which aims for 2x daily returns of the AdvisorShares Pure US Cannabis ETF, achieved a ~94% weekly return due to anticipation of a major policy change regarding marijuana reclassification by President Trump [1] Group 2: Natural Gas Market - KOLD, providing daily inverse leveraged exposure to natural gas, returned over 52% last week as U.S. natural gas prices fell due to milder winter weather forecasts and high production levels [2] Group 3: Gold Mining Sector - GDXU, a leveraged equity fund for gold miners, returned over 17% last week, driven by a 0.25% Federal Reserve rate cut and strong central bank purchasing [3] - JNUG, which seeks to return 200% of the daily performance of the MVIS Global Junior Gold Miners Index, ranked fourth with a ~14% return [4] - NUGT, aiming for 200% of the NYSE Arca Gold Miners Index performance, also benefited from optimistic financial forecasts and strong central bank buying [5] Group 4: Banking Sector - DPST, providing 3x leveraged exposure to U.S. regional banking stocks, performed well following the Fed's quarter-point rate cut and anticipated balance sheet expansion [6] Group 5: Aerospace & Defense Industry - DFEN, which aims to triple the daily return of defense industry stocks, saw strong performance due to robust Q3 earnings from major companies and positive investor sentiment regarding proposed defense budgets for FY2026 [7] Group 6: Silver Market - AGQ, offering 2x daily long leverage to silver bullion, returned ~10%+ last week, driven by tightening inventories and sustained industrial demand [8] Group 7: Pharmaceutical Sector - PILL ETF, tracking pharmaceutical companies, returned over 9% last week, supported by reduced policy uncertainty and strong growth potential in innovative therapies [9] Group 8: Semiconductor Industry - SOXS, which inversely tracks the PHLX Semiconductor Index, achieved ~9%+ returns due to investor caution regarding valuations in AI-linked stocks following a drop in Broadcom's stock [10]

Economic Data - Non-farm payroll employment in the U.S. increased by 64,000 jobs in November, following a decline of 105,000 jobs in October, surpassing economists' expectations of a 50,000 job increase [2][20] - The unemployment rate rose to 4.6 percent in November from 4.4 percent in September, higher than the anticipated increase to 4.5 percent [2][21] - Retail sales in the U.S. were virtually unchanged in October, after a downwardly revised increase of 0.1 percent in September, while economists had expected a rise of 0.2 percent [3][21][22] - Excluding motor vehicle and parts dealers, retail sales increased by 0.4 percent in October, compared to a 0.1 percent rise in September, with expectations of a 0.3 percent increase for ex-auto sales [3][22] Stock Market Performance - Major U.S. stock indices showed a lack of direction, ending the previous session modestly lower, with the Nasdaq down 0.6 percent, S&P 500 down 0.2 percent, and Dow down 0.1 percent [4][5] - Initial buying interest was observed as traders sought to acquire stocks at reduced levels, but concerns over AI spending impacted stocks like Broadcom and Oracle [5][6] - The NYSE Arca Computer Hardware Index fell by 2.9 percent, reflecting a broader pullback in computer hardware stocks [6][7] International Markets - Asian stocks fell broadly as investors awaited U.S. jobs and inflation data, with the Shanghai Composite Index down 1.1 percent and the Hang Seng Index down 1.5 percent [10][11] - Japanese stocks declined, with the Nikkei 225 Index dropping 1.6 percent, influenced by a stronger yen and expectations of a Bank of Japan rate increase [12][13] - South Korean stocks also fell, with the Kospi down 2.2 percent amid concerns over AI sector profitability [14] European Markets - European stock markets exhibited mixed performance, with the French CAC 40 Index up by 0.1 percent, while the German DAX Index and the U.K.'s FTSE 100 Index were down by 0.3 percent and 0.5 percent, respectively [16] - The U.K. unemployment rate rose slightly to 5.1 percent in the three months to October, with average earnings excluding bonuses growing by 4.6 percent year-over-year [17]

Market Overview - Stocks initially moved higher at the start of trading on Monday but quickly lost ground, with major averages ending the day modestly lower. The Nasdaq fell by 137.76 points (0.6%) to 23,057.41, the S&P 500 dipped by 10.90 points (0.2%) to 6,816.51, and the Dow decreased by 41.49 points (0.1%) to 48,416.56 [1] Sector Performance - Computer hardware stocks continued their sharp pullback from the previous session, leading to a 2.9% decline in the NYSE Arca Computer Hardware Index [4] - Software stocks also experienced considerable weakness, with the Dow Jones U.S. Software Index losing 1.5%. Other sectors such as telecom, networking, and brokerage stocks showed notable declines, while pharmaceutical and healthcare stocks performed strongly [5] Economic Data Impact - Upcoming economic reports, including the monthly jobs report for November and retail sales data for October, are expected to influence market sentiment. A report on consumer price inflation is also scheduled for release, which could affect interest rate outlooks following the Federal Reserve's recent monetary policy announcement [3][8]

Market Performance - Novo Nordisk shares have significantly decreased this year, reversing the previous surge driven by weight-loss drugs [1] Industry Trend - The report suggests a potential cooling of the market enthusiasm surrounding weight-loss drugs, which previously fueled Novo Nordisk's rapid growth [1]

Welcome back to Squawkbox. Five things to know ahead of the opening bell. The price for Warner Brothers Discovery, it could head higher.Bloomberg now reporting that both Netflix and Paramount Sky Dance have signaled they have the ability to raise their bids for the media giant. Separately, longtime media investor Mario Gabell telling Bloomberg he'll likely tender his clients. Warner Brothers Discovery Shares to Paramount in an effort to spark a bidding war for Warner.Meanwhile, computer memory maker Nvidia ...

Expansion Plans - Eli Lilly plans to announce four new facilities in the U S [1] - The site mentioned is the third of these four new facilities [1]

Pfizer has entered into an exclusive global collaboration and licensing deal with a unit of Shanghai Fosun Pharmaceutical for an early-stage weight-loss drug https://t.co/7etdqabjPx ...

Core Insights - Wave Life Sciences has made a significant advancement in the weight loss drug sector, leading to a 146% increase in its stock price following the announcement of interim data from a phase 1 clinical trial of its WVE-007 drug [1][2]. Group 1: Clinical Trial Results - The phase 1 clinical trial of WVE-007 demonstrated a reduction in total body fat by 4.5% over three months, with no significant changes observed in the placebo group [2]. - The body fat reduction achieved by WVE-007 surpasses that of semaglutide, the active ingredient in the FDA-approved obesity drug Wegovy, at the same stage of development [4]. Group 2: Safety and Tolerability - The treatment was reported to be generally safe and well-tolerated, with the CEO highlighting that WVE-007 shows fat loss comparable to GLP-1 drugs without the associated muscle loss [4][5]. Group 3: Market Performance - Following the announcement, Wave Life Sciences' stock price surged to $18.52, reflecting a market capitalization of $1 billion and a trading volume of 147 million shares [6]. - The stock's performance indicates strong investor interest in the obesity treatment sector, which is known for generating excitement around investigational drugs [6].

Market Performance - The Tel Aviv Stock Exchange saw a rise today, with the Tel Aviv 35 Index increasing by 1.14% to 3,506.55 points and the Tel Aviv 125 Index rising by 0.70% to 3,535.70 points [1] - The BlueTech Global Index, however, fell by 0.16% to 600.50 points, and the All Bond corporate bond index decreased by 0.01% to 418.12 points [1] - Total turnover in equities reached NIS 3.77 billion, while bonds totaled NIS 3.48 billion [1] Currency Exchange Rates - The representative shekel-dollar rate increased by 0.248% to NIS 3.237/$, and the shekel-euro rate rose by 0.345% to NIS 3.780/€ [2] Notable Stock Movements - Camtek experienced the largest increase on the Tel Aviv 35 Index, rising by 3.08%, followed by Tower Semiconductor at 2.45%, Elbit Systems at 2.55%, and Teva Pharmaceutical at 2.97% [2] - Bank Hapoalim led the market with a rise of 2.29% and the highest trading turnover, while Bank Leumi increased by 2.14%, Mizrahi Tefahot Bank by 0.91%, and Israel Discount Bank by 1.43% [3] - YH Dimri Construction & Development saw the largest decline on the Tel Aviv 35 Index, falling by 2.99%, with Clal Insurance down by 2.08% and Enlight Renewable Energy down by 1.70% [3]

Core Insights - AlphaTON Capital Corp has exited the SEC's "baby shelf rules" and filed a $420.69 million shelf registration statement to finance its expansion in AI and high-performance computing infrastructure supporting Telegram's Cocoon AI network [1][3][4] - The company aims to enhance its role as a critical infrastructure provider for decentralized AI computing while acquiring revenue-generating businesses within the Telegram ecosystem [3][4] Strategic Areas - **Telegram Distribution**: The company plans to establish partnerships with leading Telegram distribution applications across various sectors such as fintech, gaming, health, and sports to create strategic revenue streams [5] - **Mergers and Acquisitions**: AlphaTON has identified several high-potential acquisition targets within the Telegram ecosystem that are currently generating revenue, focusing on payments, content distribution, and blockchain-enabled services, which are expected to provide immediate cash flow and expand operational reach [5] - **Infrastructure Expansion**: The company intends to strategically deploy capital to scale its GPU infrastructure in support of Telegram's Cocoon AI network, building on existing partnerships and prior deployments of Nvidia B200 GPUs [10]